Keybanc Maintains Overweight on Tenet Healthcare, Lowers Price Target to $185

Benzinga · 01/07 15:57
Keybanc analyst Tim Rezvan maintains Tenet Healthcare (NYSE:THC) with a Overweight and lowers the price target from $200 to $185.